- $88.07m
- $722.67m
- $1.11bn
- 53
- 98
- 75
- 89
Annual income statement for Innovate, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 717 | 1,205 | 1,637 | 1,423 | 1,107 |
| Cost of Revenue | |||||
| Gross Profit | 128 | 184 | 221 | 216 | 209 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 755 | 1,228 | 1,624 | 1,397 | 1,067 |
| Operating Profit | -37.7 | -23.1 | 13.4 | 26.5 | 39.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -46.7 | -80.7 | -41.1 | -34.4 | -33.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -53.7 | -86.3 | -42 | -38.9 | -39.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -92 | -228 | -35.9 | -35.2 | -34.6 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -95.6 | -230 | -40.8 | -37.6 | -35.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.99 | -7.83 | -4.18 | -4.26 | -2.95 |